Overview of NANT Clinical Trials - Part 1
This webinar was recorded on February 16,2010
An Update on New Approaches to NeuroblastomaTherapy (NANT) Clinical Trials from Neuroblastoma Foundation on Vimeo.
Space is limited.
Reserve your Webinar seat now at:
https://www2.gotomeeting.com/register/798308411
| Join us on February 16, 2010 for an hour long presentation of Part 1 of the New Approaches to Neuroblastoma Therapy's (NANT) Clinical Trial Series. This seminar will cover the NANT's non-MIBG clinical trials. The information will be appropriate for and directed towards parents and caregivers of children with neuroblastoma. The presentation will be given by Dr. Judith Villablanca. She is the Medical Director of the Operations office for New Approaches to Neuroblastoma Therapy (NANT) Consortium and is active in the development and conduct of NANT Phase I/II trials of novel therapies for high risk neuroblastoma. Dr. Villablanca will cover the preclinical research on which the covered clinical trials are based, the eligibility criteria, and specific information regarding the clinical trials offered by the NANT. The presentation will be followed by a question and answer period in which attendees will be able to participate. |
|
| Title: |
|
Overview of NANT Clinical Trials - Part 1 |
|
| Date: |
|
Tuesday, February 16, 2010 |
|
| Time: |
|
1:00 PM - 2:00 PM PST |
|
|
| After registering you will receive a confirmation email containing information about joining the Webinar. |
|
System Requirements PC-based attendees Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista |
|
Macintosh®-based attendees Required: Mac OS® X 10.4 (Tiger®) or newer |
|